Less than 2% of infusions for pediatric rheumatic diseases result in adverse events Bioportfolio, 11 Apr 2018 16:43 EDT 11 Apr 2018 | Healio Matthew L. Stoll Following the implementation of standardized protocols for intravenous therapy…